Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats

Psychopharmacology

Volumn 204, Issue 4, 2009, Pages 607-616

  Haller, J ^a   Barna, I ^a   Barsvari, B ^a   Gyimesi Pelczer, K ^a   Yasar, S ^b,c   Panlilio, L V ^c   Goldberg, S ^c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Anxiety; Aversive; Elevated plus maze; FAAH; Rat; Stress; URB597

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CHLORDIAZEPOXIDE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVERSION; CONTROLLED STUDY; DRUG ANTAGONISM; HABITUATION; ILLUMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; TRANQUILIZING ACTIVITY;

AMIDOHYDROLASES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BENZAMIDES; CARBAMATES; CHLORDIAZEPOXIDE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION;

EID: 67349253906     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1494-7     Document Type: Article

References (44)

1. A Cippitelli N Cannella S Braconi A Duranti A Tontini A Bilbao FR Defonseca D Piomelli R Ciccocioppo 2008 Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat Psychopharmacology 198 449 460
2. V Di Marzo M Maccarrone 2008 FAAH and anandamide: is 2-AG really the odd one out? Trends Pharmacol Sci 29 229 233
3. AM Garcia FP Cardenas S Morato 2005 Effect of different illumination levels on rat behavior in the elevated plus-maze Physiol Behav 85 265 270 (Pubitemid 40840742)
4. GL Gerdeman JB Schechter ED French 2007 Context-specific reversal of cocaine sensitization by the CB(1) cannabinoid receptor antagonist rimonabant Neuropsychopharmacology 33 2747 59
5. G Griebel J Stemmelin B Scatton 2005 Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents Biol Psychiatry 57 261 267 (Pubitemid 40187370)
6. N Hajos TF Freund 2002 Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers Neuropharmacology 43 503 510 (Pubitemid 35279562)
7. N Hajos C Ledent TF Freund 2001 Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus Neuroscience 106 1 4 (Pubitemid 32831068)
8. J. Haller J. Halász E Majercsik 2004 Psychosocial conditions and the efficacy of clinically available anxiolytics Curr Drug Targets 5 655 664 (Pubitemid 39242874)
9. J Haller B Varga C Ledent I Barna TF Freund 2004 Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice Eur J Neurosci 19 1906 1912 (Pubitemid 38482578)
10. J Haller F Mátyás K Soproni B Varga B Barsy B Németh E Mikics TF Freund N Hájos 2007 Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission Eur J Neurosci 25 2445 2456 (Pubitemid 46625912)
11. MN Hill BB Gorzalka 2004 Enhancement of anxiety-like responsiveness to the cannabinoid CB1 receptor agonist HU-210 following chronic stress Eur J Pharmacol 499 291 295 (Pubitemid 39233668)
12. MN Hill ES Karacabeyli BB Gorzalka 2007 Estrogen recruits the endocannabinoid system to modulate emotionality Psychoneuroendocrinology 32 350 357 (Pubitemid 46617780)
13. Z Justinova RA Mangieri M Bortolato SI Chefer AG Mukhin JR Clapper AR King GH Redhi S Yasar D Piomelli SR Goldberg 2008 Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates Biol Psychiatry 64 930 7
14. S Kathuria S Gaetani D Fegley F Valiño A Duranti A Tontini M Mor G Tarzia G La Rana A Calignano A Giustino M Tattoli M Palmery V Cuomo D Piomelli 2003 Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 76 81 (Pubitemid 36098263)
15. MR Lalonde CA Jollimore K Stevens S Barnes ME Kelly 2006 Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells Mol Vis 12 1160 1166 (Pubitemid 44538153)
16. L Lewejohann C Reinhard A Schrewe J Brandewiede A Haemisch N Görtz M Schachner N Sachser 2006 Environmental bias? Effects of housing conditions, laboratory environment and experimenter on behavioral tests Genes Brain Behav 5 64 72
17. FM Leweke D Koethe 2008 Cannabis and psychiatric disorders: it is not only addiction Addict Biol 13 264 275
18. M Maccarrone S Rossi M Bari V De Chiara F Fezza A Musella V Gasperi C Prosperetti G Bernardi A Finazzi-Agro BF Cravatt D Centonze 2008 Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum Nature Neurosci 11 152 159
19. KA Miczek EM Weerts JA Vivian HM Barros 1995 Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics Psychopharmacology 121 38 56
20. MJ Millan 2003 The neurobiology and control of anxious states Prog Neurobiol 70 83 244 (Pubitemid 37309295)
21. FA Moreira N Kaiser K Monory B Lutz 2008 Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid- degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors Neuropharmacology 54 141 150 (Pubitemid 350299416)
22. N Naderi A Haghparast A Saber-Tehrani N Rezaii AM Alizadeh A Khani F Motamedi 2008 Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice Pharmacol Biochem Behav 89 64 75
23. PS Naidu SA Varvel K Ahn BF Cravatt BR Martin AH Lichtman 2007 Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality Psychopharmacology 192 61 70 (Pubitemid 46673891)
24. CA Opere WD Zheng M Zhao JS Lee KH Kulkarni SE Ohia 2006 Inhibition of potassium- and ischemia-evoked [3H] D-aspartate release from isolated bovine retina by cannabinoids Curr Eye Res 31 645 653 (Pubitemid 44179991)
25. P Pacher S Batkai G Kunos 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389 462 (Pubitemid 44394908)
26. S Patel CJ Hillard 2006 Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling J Pharmacol Exp Ther 318 304 311 (Pubitemid 43920770)
27. S Patel CT Roelke DJ Rademacher WE Cullinan CJ Hillard 2004 Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis Endocrinology 145 5431 5438 (Pubitemid 39564580)
28. S Patel BF Cravatt CJ Hillard 2005 Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala Neuropsychopharmacology 30 497 507 (Pubitemid 40271152)
29. S Patel CT Roelke DJ Rademacher CJ Hillard 2005 Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling Eur J Neurosci 21 1057 1069 (Pubitemid 40461057)
30. S Pellow P Chopin SE File M Briley 1985 Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 149 167 (Pubitemid 16239568)
31. D Piomelli 2003 The molecular logic of endocannabinoid signalling Nat Rev Neurosci 4 873 884 (Pubitemid 37351427)
32. D Piomelli G Tarzia A Duranti A Tontini M Mor TR Compton O Dasse EP Monaghan JA Parrott D Putman 2006 Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597) CNS Drug Rev 12 21 38 (Pubitemid 44133578)
33. L Robinson L Hinder RG Pertwee G Riedel 2003 Effects of delta9-THC and WIN-55, 212-2 on place preference in the water maze in rats Psychopharmacology 166 40 50 (Pubitemid 36286719)
34. RJ Rodgers 1997 Animal models of 'anxiety': where next? Behav Pharmacol 8 477 496 (Pubitemid 27504695)
35. RJ Rodgers J Haller J Halasz E Mikics 2003 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze Eur J Neurosci 17 1279 1286 (Pubitemid 36459782)
36. MR Romano MD Lograno 2007 Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle Invest Ophthalmol Vis Sci 48 3677 3682
37. T Rubino N Realini C Castiglioni C Guidali D Viganó E Marras S Petrosino G Perletti M Maccarrone V Di Marzo D Parolaro 2008 Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb Cortex 18 1292 1301
38. M Scherma J Medalie W Fratta SK Vadivel A Makriyannis D Piomelli E Mikics J Haller S Yasar G Tanda SR Goldberg 2008 The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition Neuropharmacology 54 129 140
39. LH Shi F Luo DJ Woodward JY Chang 2005 Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats Synapse 55 1 16 (Pubitemid 39565223)
40. V Trezza LJ Vanderschuren 2008 Cannabinoid and opioid modulation of social play behavior in adolescent rats: Differential behavioral mechanisms Eur Neuropsychopharmacol 18 519 530
41. MP Viveros EM Marco SE File 2005 Endocannabinoid system and stress and anxiety responses Pharmacol Biochem Behav 81 331 342 (Pubitemid 40807131)
42. JM Witkin ET Tzavara GG Nomikos 2005 A role for cannabinoid CB1 receptors in mood and anxiety disorders Behav Pharmacol 16 315 331 (Pubitemid 41404804)
43. D Zelena DT Kiem I Barna GB Makara 1999 α2-Adrenoreceptor subtypes regulate ACTH and β-endorphin secretions during stress in the rat Psychoneuroendocrinology 24 333 343 (Pubitemid 29118379)
44. D Zelena Z Mergl A Foldes KJ Kovacs Z Toth GB Makara 2003 Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint Am J Physiol Endocrinol Metab 285 E1110 E1117